Chronic Lymphocytic Leukemia Research Consortuim
CRC Research CRC Sites Clinical Trials For Patients Biorepository Publications & News How to Donate

Peng Huang, M.D., Ph.D.

The University of Texas
M. D. Anderson Cancer Center
Department of Molecular Pathology
7435 Fannin
Unit Number: 951
Room Number: 2SCR4.3029
Houston, TX 77054
Phone: (713) 834-6044
Fax: (713) 834-6084

Peng Huang, Ph.D.

Project Involvement: Project 5 - Novel Pharmacologic Agents in CLL

Our laboratory research are in the areas of metabolic alterations in cancer cells and mechanisms of action of novel anticancer agents. The goals our research programs are to investigate the fundamental changes in energy metabolism and redox regulation in cancer, to examine the molecular interaction between the cancer cells and anticancer drugs, and to develop novel strategies to selectively kill the malignant T-cells based on their metabolic alterations and survival pathways. Current research efforts are directed toward investigating the role of mitochondria in affecting glycolysis and drug-induced apoptosis, and examining the effect of oncogenic signals on mitochondrial respiration and ROS generation. Another important focus is the role of p53 and its associated molecules in sensing DNA damage by reactive oxygen species (ROS) and other genotoxic agents and the subsequent signaling for apoptosis. The understanding of the difference between the cancer cells and normal cells in their ATP metabolism and ROS/redox regulation will provide an important basis for developing novel agents and new strategies to selectively kill cancer cells and improve therapeutic activity and selectivity for cancer treatment.

Education & Training

Degree-Granting Education

1990 – The University of Texas Health Science Center at Houston, Graduate School of Biomedical Sciences, Houston, TX, PhD, Pharmacology

1982 – Zhongshan Medical College, Guangzhou, China, MD, Medicine

Postgraduate Training

6/1990-11/1992– Postdoctoral Fellow, Department of Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX

1/1983-8/1984 – Postgraduate Fellowship, Department of Clinical Pharmacology, Sun Yat-Sen University of Medical Sciences, Guangzhou, China

contact us home